Lisanti Capital Growth LLC Purchases Shares of 265,725 Amprius Technologies, Inc. $AMPX

Lisanti Capital Growth LLC acquired a new position in Amprius Technologies, Inc. (NYSE:AMPXFree Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 265,725 shares of the company’s stock, valued at approximately $2,795,000. Lisanti Capital Growth LLC owned about 0.21% of Amprius Technologies as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Bank of America Corp DE raised its position in Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after purchasing an additional 3,055 shares during the period. Ameritas Investment Partners Inc. grew its stake in shares of Amprius Technologies by 2,043.2% during the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock valued at $40,000 after buying an additional 9,072 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of Amprius Technologies by 61.1% in the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock worth $42,000 after buying an additional 5,951 shares during the period. Legal & General Group Plc lifted its stake in shares of Amprius Technologies by 1,385.4% in the 2nd quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after acquiring an additional 9,684 shares during the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of Amprius Technologies in the 2nd quarter valued at about $44,000. Hedge funds and other institutional investors own 5.04% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Cantor Fitzgerald raised their price target on Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Oppenheimer restated an “outperform” rating and issued a $17.00 target price on shares of Amprius Technologies in a report on Tuesday, December 23rd. Northland Securities set a $20.00 target price on shares of Amprius Technologies in a research note on Tuesday, October 7th. Roth Mkm set a $14.00 price target on shares of Amprius Technologies and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Seven analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.57.

Check Out Our Latest Research Report on AMPX

Trending Headlines about Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

  • Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
  • Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer?term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
  • Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short?term upside betting by traders — this can amplify intraday moves and volatility.
  • Neutral Sentiment: Several outlets ran takeaways asking whether recent multi?month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
  • Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings?estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
  • Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit?taking or re?rating if upcoming earnings fail to show clear progress toward profitability.

Insider Transactions at Amprius Technologies

In related news, CEO Kang Sun sold 1,000,000 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $10.60, for a total value of $10,600,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,472,306 shares of the company’s stock, valued at $15,606,443.60. This represents a 40.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction that occurred on Thursday, January 22nd. The shares were sold at an average price of $12.04, for a total value of $5,933,637.08. Following the sale, the chief technology officer directly owned 748,696 shares in the company, valued at approximately $9,014,299.84. The trade was a 39.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 3,399,331 shares of company stock valued at $37,048,615. 12.90% of the stock is owned by insiders.

Amprius Technologies Stock Down 8.5%

Shares of Amprius Technologies stock opened at $12.42 on Friday. The business has a 50 day moving average of $10.27 and a 200 day moving average of $10.02. Amprius Technologies, Inc. has a 52 week low of $1.70 and a 52 week high of $16.03. The company has a market cap of $1.62 billion, a PE ratio of -47.77 and a beta of 3.04.

Amprius Technologies (NYSE:AMPXGet Free Report) last issued its quarterly earnings data on Thursday, November 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. The business had revenue of $21.43 million for the quarter, compared to the consensus estimate of $16.45 million. On average, research analysts anticipate that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Amprius Technologies Profile

(Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Read More

Want to see what other hedge funds are holding AMPX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amprius Technologies, Inc. (NYSE:AMPXFree Report).

Institutional Ownership by Quarter for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.